Zevra Therapeutics Inc.

7.33
-0.16 (-2.14%)
At close: Apr 01, 2025, 3:59 PM
7.38
0.68%
After-hours: Apr 01, 2025, 07:55 PM EDT

Zevra Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 23.61M 27.46M 10.46M 28.65M 13.29M
Cost of Revenue 7.42M 2.94M 343K 2.06M 1.3M
Gross Profit 16.2M 24.52M 10.12M 26.59M 11.98M
Operating Income -87M -49.6M -24.84M 7.73M -4.78M
Interest Income 2.17M 4.54M 760K 248K 89K
Pretax Income -90.14M -46.05M -42.33M -8.52M -12.79M
Net Income -105.51M -46.05M -41.54M -8.55M -12.76M
Selling & General & Admin 54.87M 35.09M 15.34M 8.7M 7.92M
Research & Development 42.09M 39.81M 19.61M 10.16M 8.84M
Other Expenses 6.24M -775K n/a n/a n/a
Operating Expenses 103.2M 74.12M 34.96M 18.86M 16.76M
Interest Expense 7.35M 1.5M 335K 376K 7.09M
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 110.61M 77.06M 35.3M 20.92M 18.07M
Income Tax 15.37M n/a -786K 34K -34K
Shares Outstanding (Basic) 46.25M 35.45M 34.49M 29.77M 3.98M
Shares Outstanding (Diluted) 46.25M 35.45M 34.49M 29.77M 3.98M
EPS (Basic) -2.28 -1.3 -1.2 -0.29 -3.21
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -76.4M -48.6M -25.53M -7.89M -5.43M
Depreciation & Amortization 6.39M 1.01M 944K 257K 273K